74858-69-8 Usage
Chemical structure
A complex chemical compound consisting of a urea molecule with an ethyl and methyl group, as well as a 2-fluorophenyl and 3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-9-yl group attached to it.
Molecular weight
Approximately 374.41 g/mol
Functional groups
Urea, ethyl, methyl, 2-fluorophenyl, and 3-oxo-2,5-diazabicyclo[5.4.0]undeca-5,8,10,12-tetraen-9-yl groups.
Pharmacological and biological activities
Likely has various pharmacological and biological activities due to its intricate structure and functional groups.
Potential medicinal properties
May possess potential medicinal properties, but further research and analysis are required to determine its exact uses and properties.
Precursor for synthesis
Could act as a precursor for synthesizing other chemical compounds.
Further research
Its exact uses and properties would need to be determined through further research and analysis.
Solubility
Information on solubility is not provided, but it may be influenced by the presence of polar and nonpolar functional groups in its structure.
Stability
Information on stability is not provided, but it may be affected by factors such as temperature, pH, and exposure to light or air.
Check Digit Verification of cas no
The CAS Registry Mumber 74858-69-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,4,8,5 and 8 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 74858-69:
(7*7)+(6*4)+(5*8)+(4*5)+(3*8)+(2*6)+(1*9)=178
178 % 10 = 8
So 74858-69-8 is a valid CAS Registry Number.
InChI:InChI=1/C20H21FN4O2/c1-4-24(2)20(27)23-13-9-10-17-15(11-13)19(22-12-18(26)25(17)3)14-7-5-6-8-16(14)21/h5-11H,4,12H2,1-3H3,(H,23,27)
74858-69-8Relevant articles and documents
Benzodiazepine derivatives
-
, (2008/06/13)
This invention provides benzodiazepine derivatives of the general formula STR1 wherein R1 represents a lower alkyl group, R2 represents a hydrogen atom or a lower alkyl group, R3 represents a halogen atom and R4 represents a hydrogen or halogen atom and either R5 represents a hydrogen atom or a lower alkyl group and R6 represents a lower alkyl, lower hydroxyalkyl or lower acyloxyalkyl group or R5 represents a hydrogen atom and R6 represents an aryl or lower aralkyl group or R5 and R6 together with the nitrogen atom to which they are attached represent a 3-membered to 7-membered heterocycle which, when it is at least 5-membered, can contain as a ring member an oxygen or sulphur atom or a group of the formula >N-R7 in which R7 represents a hydrogen atom or a lower alkyl group, and pharmaceutically acceptable acid addition salts thereof, which possess aldosterone-antagonistic properties and are accordingly suitable for the control or prevention of heart failure, of hepatic ascites, of primary aldosteronism and of idiopathic hypertension. Some of these compounds and salts also inhibit the intestinal resorption of cholesterol and are according suitable for the prevention or control of atherosclerosis. Also provided are a process for the manufacture of the above end products and novel intermediates therefor.